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Short Communication
Single nucleus transcriptomics data integration recapitulates
the major cell types in human liver
Klev Diamanti,1 Juan Salvador Inda Díaz,2 Amanda Raine,3 Gang Pan,1
Claes Wadelius1 and Marco Cavalli1
Science for 1Life Laboratory, Department of Immunology, Genetics and Pathology, and 3Life Laboratory, Department
of Medical Sciences, Molecular Medicine, Uppsala University, Uppsala, 2Department of Mathematical Sciences,
Chalmers University of Technology and University of Gothenburg, Gothenburg, Sweden
Aim: The aim of this study was to explore the benefits of
data integration from different platforms for single nucleus
transcriptomics profiling to characterize cell populations in
human liver.
Methods: We generated single‐nucleus RNA sequencing data
from Chromium 10X Genomics and Drop‐seq for a human liver
sample. We utilized state of the art bioinformatics tools to
undertake a rigorous quality control and to integrate the data
into a common space summarizing the gene expression
variation from the respective platforms, while accounting for
known and unknown confounding factors.
Results: Analysis of single nuclei transcriptomes from both
10X and Drop‐seq allowed identification of the major liver cell
types, while the integrated set obtained enough statistical
power to separate a small population of inactive hepatic stellate
cells that was not characterized in either of the platforms.
Conclusions: Integration of droplet‐based single nucleus
transcriptomics data enabled identification of a small cluster of
inactive hepatic stellate cells that highlights the potential of
our approach. We suggest single‐nucleus RNA sequencing
integrative approaches could be utilized to design larger and
cost‐effective studies.
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INTRODUCTION
THE HUMAN LIVER represents a heterogeneous butwell‐defined tissue composed of parenchymal cells
(PCs) and non‐PCs. Hepatocytes (HCs) constitute the
PCs and the largest part of the organ, and are involved in
diverse metabolic processes such as drug metabolism, bile
acid synthesis, and lipid metabolism. Non‐PCs regulate
HCs through signaling factors they release.1 Non‐PCs in-
clude, among others, liver sinusoidal endothelial cells
(LSECs), macrophages known as Kupffer cells (KCs) that
reside in the sinusoid capillary lumen, and hepatic stellate
cells (HSCs) that act as storage depots for fat and vitamin A
when in quiescent form, and undergo a morphological
transformation into myofibroblastic cells upon activation
following liver injury.2
The study of single‐cell transcriptomes (scRNA‐seq)
provides detailed information on the heterogeneity of
tissues and organs, unveils novel or rare cell popula-
tions or subpopulations, allows tracking developmental
trajectories and cell lineages, and potentially leads to
new biological and clinical insights.3–5 After the
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pioneering report on the exploration of single cell
transcriptomes more than a decade ago,6 multiple meth-
odologies have been developed.3,5,7 Selection of the
suitable scRNA‐seq method should be primarily based
on evaluation of the nature of the samples and the
costs. Other key parameters to take into account
include the correspondence between the quantification
of sequencing reads and mRNA concentration
(accuracy), and the probability of capturing a specific
mRNA transcript (sensitivity).3 The biological question
(s) driving the design of the experiment should aim at
retaining the balance between the qualitative and
quantitative aspects of the methodology.
A major bottleneck in carrying out scRNA‐seq in
tissue samples is posed by the limited availability of
fresh tissue and, most often, by the technical challenges
in isolating rare cell types.8 The majority of biobanks
store flash‐frozen tissue samples that subsequently do
not facilitate isolation of viable single cells for
scRNA‐seq. However, several studies have shown that
the transcriptomics profile of intact single nuclei closely
resembles the one of the original cells.8–10 Droplet
microfluidics methods designed for scRNA‐seq profiling
have been adapted to carry out single‐nucleus RNA
sequencing (snRNA‐seq).9,10 Popular droplet‐based
approaches suitable for snRNA‐seq include Chromium
10X Genomics11 and Drop‐seq.12 Although the overall
strategy of both methodologies involves single nuclei
encapsulation in droplets, cell barcoding to track cells,
and unique molecular identifiers (UMIs) to count
unique mRNAs, they differ in the cDNA amplification
and in‐droplet reactions.7,13 Overall, 10X offers better
sensitivity and less technical noise, albeit at greater mon-
etary cost.13 Several technical differences between the
protocols could potentially account for the increased
resolution of 10X over Drop‐seq. For instance, in 10X
the reverse transcription is carried out inside the small
volume of the droplets, whereas in Drop‐seq the beads,
with captured mRNA molecules on the surface, are
released from the emulsion before the reverse transcrip-
tion is carried out in a bulk reaction.
Transcriptomics analysis of human liver tissue at
single cell level has recently painted a detailed view of
the organ design.14–17 Integrating and exploring single
nuclei transcriptomes from different technologies could
help uncover cell subpopulations previously indecipher-
able in individual experiments due to resolution or
power limitations. Another advantage of data integra-
tion is the increased number of features in the
integrated space that enables higher accuracy for cluster
and marker identification. Here, we integrated
snRNA‐seq from a human liver tissue sample using
10X and Drop‐seq, and we explored cell populations
in the integrated space. The integration of single nuclei
transcriptomics profiles with differing resolution
recapitulated the major cell types of the human liver,
and increased the statistical power that allowed identifi-
cation of cell populations not identified in the respective
experiments. Finally, we discussed the benefits and the
caveats of the integrative approach.
METHODS
Ethics statement
THE USE OF the liver tissue sample used in this studywas approved by the Uppsala regional ethics commit-
tee (Dnr: 2014/433).
Nuclei preparation
The human liver tissue sample was provided by Professor
Per Artursson at Uppsala University. The sample was
obtained from a partial hepatectomy of a male patient
with colon cancer and hepatic metastasis. The patient
had provided written consent for the use of the biological
sample for scientific research. Part of the resection, charac-
terized as tumor‐free by a pathologist, was flash‐frozen
and subsequently used in this study.
Nuclei suspension was prepared using the gentleMACS
dissociator (Miltenyi Biotec, BergischGladbach, Germany)
as described earlier by Cavalli et al.17 The liver nuclei were
resuspended in 2 mL phosphate‐buffered saline with
0.01% bovine serum albumin for the Drop‐seq prepara-
tion and RiboLock RNase Inhibitor (Thermo Fisher
Scientific, Waltham, MA, United States) and filtered using
30 μm MACS SmartStrainers. The nuclei suspension was
evaluated for purity and concentration using the Countess
II Automated Cell Counter (Thermo Fisher Scientific,
Waltham, MA, United States) by staining the nuclei with
Trypan blue and was adjusted to a final concentration of
~300 nuclei/μL for the Drop‐seq using the Nadia
instrument (Dolomite Bio, Royston, Hertfordshire, UK).
cDNA library preparation and sequencing
Single nuclei transcriptomics data for Chromium 10X was
obtained from Cavalli et al.17 Drop‐seq was carried out
using the Nadia instrument (Dolomite Bio) for nuclei
droplet encapsulation as previously described,12 with the
exception that emulsion breakage was undertaken by
filtration through a 5‐μMuberstrainer (pluriSelect, Leipzig,
Germany). cDNA amplification was carried out by
polymerase chain reaction (4 + 13 cycles) using aliquots
of 10 000 beads. Three cDNA amplification reactions,
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corresponding to 30 000 beads, were pooled and purified
twice by 0.6X AMPure beads (Beckman Coulter Life
Sciences, Indianapolis, IN, United States) and 600 pg of
amplified DNA was used as input for Nextera library
(Illumina, San Diego, CA, United States) preparation.
Libraries were sequenced using a custom sequencing
oligo12 on a IlluminaNovaSeq SP flow cell as follows: read
1, 25 bp; read 2, 91 bp; and index read, 8 bp.
Data preprocessing, nuclei clustering, and
differential expression
The raw base call files from the sequencer for the 10X
experiment were demultiplexed using themkfastq function
of the cellranger tool version 2.2 provided by 10X Geno-
mics. Raw base call files from the Drop‐seq experiment
were converted to fastq using the tool bcl2fastq version
2.20 by Illumina. Fastq files from 10X and Drop‐seq were
imported in the dropSeqPipe pipeline (https://github.com/
Hoohm/dropSeqPipe) for alignment, quantification, and
calculation of the UMI matrices (Table S1).
Unfiltered matrices containing UMIs for both experi-
ments were used for the downstream analysis (Fig. S1).
We applied debris identification using expectation
maximization (DIEM) to identify empty/contaminated
droplets and assess the quality of droplets that otherwise
“appear healthy”.18 Droplets containing less than 200
UMIs or five genes were assigned to the predefined debris
set, while the rest were included in the test set (Fig. S2).
DIEM measures the distance of clusters of droplets from
the test set to those of the debris set. The minimum
distance that any of the k = 30 clusters from the test set is
required to have from the debris set was 0.2 (Fig. S3). This
filtering process resulted in 1386 nuclei for Drop‐seq and
2475 nuclei for 10X.
We used the SCTransform function from Seurat as a
first normalization approach on both datasets, control-
ling for mitochondrial percentage.19,20 We selected
3592 genes with residual variance above 1.3. Next,
we used the raw mRNA counts and ZINB‐WaVE, a
zero‐inflated negative binomial model developed for
scRNA‐seq to integrate single nucleus datasets originat-
ing from different technologies.21 A matrix of (K = 20)
surrogate variables that represented unwanted variation
in the dataset was calculated using the 3592 genes from
the previous step, the confounding factors included were
the snRNA‐seq methodology (Drop‐seq and 10X) and
the log‐transformed mRNA counts per cell, and a general
regularization parameter (epsilon = 1000). The same ma-
trix was used to construct a shared nearest neighbors
graph and cluster the cells using the Louvain algorithm
(functions FindNeighbors and FindCluster from the R
package Seurat). The average silhouette width for differ-
ent resolution levels in the clustering algorithm was
calculated (Fig. S4a) and six clusters (HC, KC, LSEC,
quiescent HSC [qHSC], active HSC [aHSC], and inacti-
vate HSC [iHSC]) were obtained for resolution 0.3 in
the integrated set (Figs S4,S5). Average silhouette width
is used to assess the quality of the clustering, and it
ranges between 1 (poor clustering) and 1 (good
clustering). Clusters did not show notable biases due
to cell cycle, number of genes, or number of UMIs
(Fig. S5).
We repeated the dimensionality reduction and cluster-
ing on the original Drop‐seq and 10X, with the difference
of using the top 1000 variable genes from each and the
log values of mRNA counts per cell as covariates on each
dataset. For 10X, five clusters (HC, KC, LSEC, qHSC, and
aHSC) were defined at resolution 0.5, while four clusters
(HC, KC, LSEC, and aHSC) were identified in Drop‐seq
for resolution 0.4 (Figs S4,S5). Similar to the integrated
set, these datasets did not show any noteworthy influence
of cell cycle, number of genes, or number of UMIs
(Fig. S5). The adjusted Rand index between the clusters
for Drop‐seq and 10Xwas 0.84 and 0.82, respectively. This
indicates that the integration does not distort the general
structure of the datasets. Differential expression analysis
among clusters was calculated with a Wilcoxon test on
the raw counts and visualized on a heatmap for the
SCTransform data for the top 10 differentially expressed
genes and cell type markers (Fig. S6).
Data availability
All relevant data are presented within the article and its
supporting information files. Raw data is available at the
European Nucleotide Archive under the EBI BioStudies ac-
cession number S‐BSST324. Specifically, the accession
numbers for the experiments are ERX3897748 and
ERX4298533. These data will be also available from the
corresponding author upon request.
RESULTS AND DISCUSSION
IN THE PRESENT study we integrated transcriptomicsdata from human liver obtained from two
droplet‐based techniques for high‐throughput snRNA‐
seq, 10X and Drop‐seq.17 Raw data underwent extensive
quality control, resulting in 2475 and 1386 nuclei for
10X and Drop‐seq, respectively (Table S1). Finally, the
set of 3861 nuclei from the two methodologies was inte-
grated using ZINB‐WaVE and further downstream analysis
was carried out (see “Methods”).21
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Fine‐tuning the clustering parameters in combination
with correcting for various confounding factors revealed
six distinct cell populations that were subsequently anno-
tated based on the expression of cell‐type specific markers
curated from other relevant liver studies (see “Methods”;
Figs S1–S4).14–16,22,23 Specifically in the integrated set we
identified 2761HCs, 305 LSECs, 82 KCs, and three clusters
of HSCs representing different activation states, namely
584 qHSCs, 94 aHSCs, and 35 iHSCs (Figs 1,S4–S6).
HCs were the most abundant cell type in individual ex-
periments, as well as in the integrated set. They were anno-
tated by the expression of well‐known marker genes
includingG6PC, PCK1, PLG, FGL1, C3, and F5, and several
genes encoding for proteins in the cytochrome P450 fam-
ily or in the complement cascade (Figs 1,S7, Table S2).
Liver sinusoidal endothelial cells were also identified
from both 10X and Drop‐seq independently and they
formed a distinct cluster in the integrated space. The LSEC
marker genes included FLT1, STAB1, OIT3, AKAP12,
PTPRB, NOSTRIN, and PLEKHG1 (Figs 1,S7, Table S2).
Similarly, KCs were defined using both single nucleus
transcriptomics approaches and were annotated by the ex-
pression of immunity and macrophage/monocyte‐specific
genes such as CD163, CD74, IL18, MYO1F, FGD2, SAT1,
MARCO, and MSR1 (Figs 1,S7, Table S2).
The identification of several clusters of HSCs highlighted
the increased resolution that can be achieved by integrat-
ing data from various sources. Both 10X and Drop‐seq
identified a cluster of aHSCs characterized by signature ex-
pression of genes such as PDGFRB, ADAMTS2, LAMA2,
LAMB1, andDCN and several genes encoding for collagen,
metalloproteinases and other extracellular matrix proteins
(Figs 1,S7, Table S2). Quiescent HSCs, defined by genes
including UCHL1, NTM, NRXN1, and PCDH7, were iden-
tified solely by 10X, whereas the lower resolution of
Drop‐seq prevented the detection of qHSCs, despite a
subset of nuclei expressing some of the cluster markers
(Fig. 1).
Recovery from liver injury is accompanied by reduction
of the fibrosis that is characterized by the disappearance of
aHSCs, which can be eliminated through apoptosis or
Figure 1 UMAP plots for Drop‐seq, Chromium 10X Genomics, and the integrated set of single‐nucleus RNA sequencing data for a hu-
man liver sample (Fig. S5). Connections fromDrop‐seq and 10X towards the integrated set represent contributing nuclei to the clusters
of the integration. All connections to inactivate hepatic stellate cells (iHSC) are in black; the remaining connections are in gray. An in-
teractive version of the figure is also available (Data S1). aHSC, active HSC; HC, hepatocytes; KC, Kupffer cells; LSEC, liver sinusoidal
endothelial cells; qHSC, quiescent HSC.
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enter a senescence state that prompts an
immune‐mediated removal. Recent experiments in mice
have indicated that aHSCs can revert into an inactivated,
quiescent‐like phenotype once the injury source is
removed.24 Inactivated HSCs display a distinct gene ex-
pression profile marked by downregulation of fibrogenic
genes (COL1A1, COL1A2, ACTA2, TGFBR1, and TIMP1)
and upregulation of some quiescence‐associated genes
(PPARG and BAMBI), but not adipogenic genes such as
ADFP, ADIPOR1, or GFAP.25 Although more similar to
qHSCs than to aHSCs, iHSCs do not fully revert to qHSCs,
and are primed to be quickly reactivated by reoccurring
fibrogenic stimuli.26,27
In the integrated space we identified a small cluster of 35
nuclei with a transcriptomics profile bearing gene markers
of both qHSCs and aHSCs, likely representing a popula-
tion of iHSCs. The presence of this cluster was signified
by the negative silhouette width for a subset of nuclei from
the aHSC in 10X, where the majority of iHSCs originate
from (Fig. S4c). As expected, the analysis of the genes de-
fining the cluster revealed lower expression of extracellular
matrix proteins with respect to aHSC (Fig. S8a), while the
expression of some collagen proteins such as COL5A3was
retained (Fig. S7). The cluster also showed an increase in
expression of quiescence‐associated genes with respect to
aHSC including NTM, NRXN1, and PTN, but not
ADIPOR1 (Fig. S8b). Finally, the cluster also showed ex-
pression of the anti‐apoptotic heat‐shock protein HSPA1A
and HSPA1B that assists iHSCs to avoid apoptotic clear-
ance, in contrast to aHSCs that do not express HSPA1A/
B25 (Table S3).
The iHSCs cluster stems from the aHSCs and originates
from nuclei captured with 10X. This cluster was part of
aHSC in the 10X dataset (Figs 1,S5), and as a result of
the integration with Drop‐seq its marker‐genes gained
power that enabled independent clustering. This is
supported by a larger average silhouette width in the case
when iHSCs nuclei have their own cluster, compared to
when they are grouped together with aHSCs cells
(Figs S4,S9).
Single‐nucleus RNA sequencing integration allows
simultaneous analysis of datasets originating from differ-
ent samples and/or sequencing technologies. However,
it could lead to distorted cell clustering that does not re-
flect the original grouping of the cells in each individual
dataset. Here, we have used integration methodologies
developed for scRNA‐seq on snRNA‐seq. The integrated
space showed clusters of nuclei with specific cellular
identity that resembled those on each individual dataset.
Moreover, snRNA‐seq data integration unveiled a cell
type masked on the analysis of each dataset separately.
To our knowledge, this is the first study to integrate
snRNA‐seq experiments originating from different tech-
nologies (Fig. 1). Analysis of the individual datasets
from Drop‐seq and 10X showed that the latter contrib-
uted largely to the identification of more cell types,
whereas the former played an important role to increase
the quantity of genes and nuclei. The results from the
integrated set highlighted its augmented power to detect
smaller subpopulations of cells that ultimately enhance
the discovery and interpretability. Guided by this con-
clusion, we suggest that transcriptomic studies might
benefit from combining single cell or nucleus experi-
ments between more costly technologies offering high
sensitivity (e.g. Chromium 10X Genomics) and technol-
ogies that, due to the limited cost, will allow inclusion
of additional samples (e.g. Drop‐seq). Integrating data
from different sources should enable the discovery of
rare/small cell populations in larger cohorts while
balancing quality and quantity.
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SUPPORTING INFORMATION
ADDITIONAL SUPPORTING INFORMATION may befound online in the Supporting Information section
at the end of the article.
Data S1 Interactive visualization of Figure 1 in 3D.
Figure S1 Individual knee‐plots for Drop‐seq and 10X
datasets.
Figure S2 Violin plots showing the distribution of number
of genes, unique molecular identifiers (UMIs), and mito-
chondrial genes.
Figure S3 Distances of clusters of nuclei between back-
ground and testing sets in DIEM.
Figure S4 Average silhouette value for 10X, Drop‐seq, and
the integrated set.
Figure S5 UMAP plots for Drop‐seq, 10X, and integrated
sets.
Figure S6 Expression matrix for the top 10 differentially
expressed genes.
Figure S7 UMAP plots for the curated list of cell‐type spe-
cific markers.
Figure S8Comparison ofmarker‐gene expression between
active hepatic stellate cells (aHSC) and inactive hepatic
stellate cells (iHSC).
Figure S9 Silhouette widths for clusters in 10X and the in-
tegrated set.
Table S1Collection of arguments used to run dropSeqPipe
for Drop‐seq and 10X.
Table S2 Cell‐type specific markers used to mark each
cluster.
Table S3 Cluster‐specific marker genes.
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